CDMO News
Aramis Biotechnologies Partners with Biodextris for Clinical-Scale Manufacturing of Influenza Vaccine
Aramis Biotechnologies and Biodextris Inc. have formed a strategic partnership to advance the production of a seasonal influenza vaccine, focusing on supporting clinical trials and addressing the need for better protection of at-risk populations. The agreement will see Biodextris, a
20 December 2024